Notable awards FRS (2015)
FRCPC | Name Daniel Drucker | |
 | ||
Born Daniel Joshua Drucker
June 23, 1956 (age 67)
Montreal, Quebec ( 1956-06-23 ) Fields Incretins
Diabetes
Exenatide
Gut hormones
Glucagon-like peptides Institutions University of Toronto
Massachusetts General Hospital Alma mater University of Toronto (MD) | ||
Daniel Joshua Drucker (born 1956) FRS FRCPC MD is a professor of medicine at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto. In 1996, Drucker first identified the proliferative effects that GLP-2 has on small bowel proliferation in rats.
Contents
Education and career
Drucker graduated in medicine from the University of Toronto (1980), and received postgraduate training (medicine and endocrinology) at Johns Hopkins Hospital (1980–81), the University of Toronto (1980–84) and the Massachusetts General Hospital and Harvard Medical School (1984–87).
Awards and honours
Drucker was elected a Fellow of the Royal Society (FRS) in 2015. His certificate of election reads:
Drucker has received numerous other national and international awards in recognition of his research accomplishments elucidating the mechanisms of action and therapeutic potential of enteroendocrine hormones. These include the Prix Galien Canada for outstanding academic research (2008), the Donald F. Steiner Award for Outstanding Diabetes Research from the University of Chicago (2007), the Clinical Investigator Award from the Endocrine Society (2009), the Claude Bernard Prize from the European Association for the Study of Diabetes (2012), the Oon International Award and Lecture from the University of Cambridge (2014), the Banting Medal for Scientific Achievement from the American Diabetes Association (2014) and the Manpei Suzuki Foundation International Prize for Diabetes (2014). Drucker was named an Officer of the Order of Canada in 2015.